Anexsia 5/325

   
Google
 
Web NewDrugInformation.com

Anexsia 5/325


Drug - Anexsia 5/325
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Hydrocodone Bitartrate
Multiple ingredients are in alphabetical order.

Strength - 325MG;5MG
The potency of the active ingredient(s), Acetaminophen; Hydrocodone Bitartrate. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Anexsia 5/325. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040409
The FDA assigned number to Anexsia 5/325. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Anexsia 5/325. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 20, 2000
The date Anexsia 5/325 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Anexsia 5/325. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Anexsia 5/325 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Inc
The full name of the firm holding legal responsibility for the new application of Anexsia 5/325.

Anexsia 5/325